Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001632384-26-000002

Director acquired 1,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Galante Joseph C Director 2026-03-18 Grant or award +1,800 $2.80 $5,040 63,656 D
Loading xslF345X06/wk-form4_1774041820.xml…